首页> 美国卫生研究院文献>Journal of Visualized Experiments : JoVE >Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
【2h】

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

机译:使用INTERCEPT血液系统制备双剂量Buffy外套血小板产品并进行病原灭活

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Blood centers are faced with many challenges including maximizing production yield from the blood product donations they receive as well as ensuring the highest possible level of safety for transfusion patients, including protection from transfusion transmitted diseases. This must be accomplished in a fiscally responsible manner which minimizes operating expenses including consumables, equipment, waste, and personnel costs, among others.Several methods are available to produce platelet concentrates for transfusion. One of the most common is the buffy coat method in which a single therapeutic platelet unit (≥ 2.0 x1011 platelets per unit or per local regulations) is prepared by pooling the buffy coat layer from up to six whole blood donations. A procedure for producing "double dose" whole blood derived platelets has only recently been developed.Presented here is a novel method for preparing double dose whole blood derived platelet concentrates from pools of 7 buffy coats and subsequently treating the double dose units with the INTERCEPT Blood System for pathogen inactivation. INTERCEPT was developed to inactivate viruses, bacteria, parasites, and contaminating donor white cells which may be present in donated blood. Pairing INTERCEPT with the double dose buffy coat method by utilizing the INTERCEPT Processing Set with Dual Storage Containers (the "DS set"), allows blood centers to treat each of their double dose units in a single pathogen inactivation processing set, thereby maximizing patient safety while minimizing costs. The double dose buffy coat method requires fewer buffy coats and reduces the use of consumables by up to 50% (e.g. pooling sets, filter sets, platelet additive solution, and sterile connection wafers) compared to preparation and treatment of single dose buffy coat platelet units. Other cost savings include less waste, less equipment maintenance, lower power requirements, reduced personnel time, and lower collection cost compared to the apheresis technique.
机译:血液中心面临着许多挑战,包括最大程度地提高其所接受的血液制品捐赠的产量,以及确保输血患者的最高安全水平,包括防止输血传播的疾病。这必须以一种对财务负责的方式来实现,该方式应将包括消耗品,设备,废物和人员成本等在内的运营费用减至最少。有几种方法可以生产用于输血的血小板浓缩液。最常见的一种是血沉棕黄层的方法,其中通过将血沉棕黄层的厚度从最多六个整体合并起来来制备单个治疗性血小板单位(每单位或根据当地法规≥2.0 x10 11 血小板)献血。一种生产“双剂量”全血来源的血小板的方法最近才被开发出来。这里介绍了一种新方法,该方法可从7块血沉棕黄层的池中制备双剂量全血来源的血小板浓缩液,然后用INTERCEPT Blood治疗双剂量单位。病原体灭活系统。 INTERCEPT旨在灭活捐赠血液中可能存在的病毒,细菌,寄生虫和污染的供体白细胞。通过将INTERCEPT处理套件与双存储容器(“ DS套件”)配合使用,将INTERCEPT与双剂量血沉棕黄层涂层法配对使用,可使血液中心在单个病原体灭活处理集中处理每个其双剂量单位,从而最大程度地提高患者安全性同时将成本降到最低。与单剂量血沉棕黄层血小板单位的制备和处理相比,双剂量血沉棕黄层方法需要的血沉棕黄层更少,并且消耗品的使用减少了多达50%(例如,池组,过滤器组,血小板添加剂溶液和无菌连接晶片)。 。与单采血液分离术相比,其他节省的成本包括更少的浪费,更少的设备维护,更低的功率需求,更少的人员时间以及更低的收集成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号